Tango Therapeutics, Inc. Public Float
Tango Therapeutics, Inc. (TNGX) had Public Float of $528.40 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $528.40M.
- 2024-06-28: Entity Public Float $855.10M.
- 2023-06-30: Entity Public Float $177.40M.
- 2022-06-30: Entity Public Float $302.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $528.40M 10-K · filed 2026-03-05 |
| 2024-06-28 | $855.10M 10-K · filed 2025-02-27 |
| 2023-06-30 | $177.40M 10-K · filed 2024-03-18 |
| 2022-06-30 | $302.30M 10-K · filed 2023-03-27 |
| 2021-06-30 | $189.80M 10-K · filed 2022-03-28 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |